Home
GRFS
GRFS News

Latest Grifols S.A. (GRFS) News on July 27, 2024

Three Stocks Estimated To Be Trading With Intrinsic Discounts Between 35.9% And 49.7%

Simply Wall St.

14 days ago

Three Stocks Estimated To Be Trading With Intrinsic Discounts Between 35.9% And 49.7%

Grifols Family Shareholders, Brookfield in Talks To Take Firm Private

Investopedia

17 days ago

Grifols Family Shareholders, Brookfield in Talks To Take Firm Private

MT Newswires

18 days ago

Grifols Shares Surge on Take-Private Talks

MT Newswires

18 days ago

European Equities Close Mixed in Monday Trading

Morningstar Research

18 days ago

Analyst Report: Grifols, S.A.

Beleaguered Spanish Drug Firm Grifols Stock Jumps On Monday - Here's Why

Benzinga

18 days ago

Beleaguered Spanish Drug Firm Grifols Stock Jumps On Monday - Here's Why

MT Newswires

18 days ago

Market Chatter: Grifols Says Founding Family, Brookfield Weigh Takeover Bid

Grifols Says Founding Family, Brookfield Weigh Takeover Bid

Bloomberg

19 days ago

Grifols Says Founding Family, Brookfield Weigh Takeover Bid

MT Newswires

21 days ago

Sector Update: Health Care

MT Newswires

21 days ago

Grifols Appoints New Chief Financial Officer

Grifols’ Biotest to achieve USD 1 billion in US sales of Yimmugo® over next seven years

GlobeNewswire

a month ago

Grifols’ Biotest to achieve USD 1 billion in US sales of Yimmugo® over next seven years

Grifols Leads Three Stocks That May Be Priced Below Their Estimated True Value

Simply Wall St.

a month ago

Grifols Leads Three Stocks That May Be Priced Below Their Estimated True Value

Grifols completes sale of a 20% equity stake in SRAAS and forges strategic alliance with Haier Group

GlobeNewswire

a month ago

Grifols completes sale of a 20% equity stake in SRAAS and forges strategic alliance with Haier Group

Biotest wins FDA approval for plasma protein therapy

Pharmaceutical Technology

a month ago

Biotest wins FDA approval for plasma protein therapy

Grifols prepares for late-stage plans with plasma-derived medicines in 2024

Pharmaceutical Technology

a month ago

Grifols prepares for late-stage plans with plasma-derived medicines in 2024

MT Newswires

a month ago

Grifols' Biotest Gets FDA Approval for Yimmugo

Grifols’ Biotest receives FDA approval for innovative Yimmugo® immunoglobulin to treat primary immunodeficiencies

GlobeNewswire

a month ago

Grifols’ Biotest receives FDA approval for innovative Yimmugo® immunoglobulin to treat primary immunodeficiencies

Morningstar Research

2 months ago

Analyst Report: Grifols, S.A.

GigaGen doses first subject in Phase I advanced solid tumour trial

Clinical Trials Arena

2 months ago

GigaGen doses first subject in Phase I advanced solid tumour trial

Morningstar Research

2 months ago

Analyst Report: Grifols, S.A.

Short Seller Gains on Grifols Bet That Tripped Elliott Spinout

Bloomberg

3 months ago

Short Seller Gains on Grifols Bet That Tripped Elliott Spinout

MT Newswires

3 months ago

Grifols Shares Rise as Haier Deal Set to Close in June

Grifols 2023 Annual Report on Form 20-F filed with the SEC

PR Newswire

3 months ago

Grifols 2023 Annual Report on Form 20-F filed with the SEC

Grifols Celebrates 50 Years of Manufacturing Life-Changing Plasma-Derived Medicines for Patients at Flagship Site in Clayton, N.C.

GlobeNewswire

3 months ago

Grifols Celebrates 50 Years of Manufacturing Life-Changing Plasma-Derived Medicines for Patients at Flagship Site in Clayton, N.C.

Spanish drug maker Grifols will bring in independent directors, chairman tells newspaper

Reuters

3 months ago

Spanish drug maker Grifols will bring in independent directors, chairman tells newspaper

Grifols Plans First Bond Sale Since Short Seller Attack

Bloomberg

4 months ago

Grifols Plans First Bond Sale Since Short Seller Attack

Grifols Procleix ArboPlex Assay® Receives CE Mark, the First and Only 4-in-1 NAT for Arbovirus Screening

GlobeNewswire

4 months ago

Grifols Procleix ArboPlex Assay® Receives CE Mark, the First and Only 4-in-1 NAT for Arbovirus Screening

Grifols Drops as Regulator Finds ‘Relevant Deficiencies’

Bloomberg

4 months ago

Grifols Drops as Regulator Finds ‘Relevant Deficiencies’

Morningstar Research

5 months ago

Analyst Report: Grifols, S.A.

Health Care Roundup: Market Talk

The Wall Street Journal

5 months ago

Health Care Roundup: Market Talk

Reuters

5 months ago

UPDATE 2-Europe's STOXX 600 logs weekly gains, US jobs data in focus

Morningstar Research

5 months ago

Analyst Report: Grifols, S.A.

Spanish Healthcare Firm Grifols Hit With New Gotham City's Short Report, Faces Questions Regarding Transparency, Integrity, Ethical Conduct

Benzinga

5 months ago

Spanish Healthcare Firm Grifols Hit With New Gotham City's Short Report, Faces Questions Regarding Transparency, Integrity, Ethical Conduct

Morningstar Research

5 months ago

Analyst Report: Grifols, S.A.

Grifols Drops 35% as Management Flags Risk of Zero Cash Flow

Bloomberg

5 months ago

Grifols Drops 35% as Management Flags Risk of Zero Cash Flow

Activists Load Up on Temenos, Grifols After Short Seller Reports

Bloomberg

5 months ago

Activists Load Up on Temenos, Grifols After Short Seller Reports

GRFS or ZTS: Which Is the Better Value Stock Right Now?

Zacks

5 months ago

GRFS or ZTS: Which Is the Better Value Stock Right Now?

Grifols announces positive topline phase 3 fibrinogen clinical trial results

GlobeNewswire

5 months ago

Grifols announces positive topline phase 3 fibrinogen clinical trial results

Charles Brandes Adjusts Position in Grifols SA

GuruFocus.com

5 months ago

Charles Brandes Adjusts Position in Grifols SA

Charles Brandes Bolsters Position in Grifols SA

GuruFocus.com

5 months ago

Charles Brandes Bolsters Position in Grifols SA

Here's Why Grifols (GRFS) Is a Great 'Buy the Bottom' Stock Now

Zacks

6 months ago

Here's Why Grifols (GRFS) Is a Great 'Buy the Bottom' Stock Now

Another sneaky Biden energy move

Yahoo Finance

6 months ago

Another sneaky Biden energy move

GRFS or ZTS: Which Is the Better Value Stock Right Now?

Zacks

6 months ago

GRFS or ZTS: Which Is the Better Value Stock Right Now?

Navigating Market Uncertainty: Intrinsic Value of The Home Depot Inc

GuruFocus.com

6 months ago

Navigating Market Uncertainty: Intrinsic Value of The Home Depot Inc

Reuters

6 months ago

UPDATE 1-Spain's Grifols sues Gotham City fund, JV over damaging report

Grifols Sues Gotham City Over ‘False’ Short-Seller Report

Bloomberg

6 months ago

Grifols Sues Gotham City Over ‘False’ Short-Seller Report

Reuters

6 months ago

Spain's Grifols sues Gotham City fund, JV over damaging report

BP Eyes FID for Trinidad's Calypso Deepwater Gas Field by 2025

Zacks

6 months ago

BP Eyes FID for Trinidad's Calypso Deepwater Gas Field by 2025

The Return Trends At Fluor (NYSE:FLR) Look Promising

Simply Wall St.

6 months ago

The Return Trends At Fluor (NYSE:FLR) Look Promising

Robinhood Markets, Inc. (HOOD) Stock Dips While Market Gains: Key Facts

Zacks

6 months ago

Robinhood Markets, Inc. (HOOD) Stock Dips While Market Gains: Key Facts

Will Gentex (GNTX) Beat Estimates Again in Its Next Earnings Report?

Zacks

6 months ago

Will Gentex (GNTX) Beat Estimates Again in Its Next Earnings Report?

Reuters

6 months ago

UPDATE 1-Cleveland-Cliffs argued its US Steel bid was worth more than Nippon Steel's, filing shows

Cleveland-Cliffs argued its US Steel bid was worth more than Nippon Steel's, filing shows

Reuters

6 months ago

Cleveland-Cliffs argued its US Steel bid was worth more than Nippon Steel's, filing shows

Health Care Roundup: Market Talk

The Wall Street Journal

6 months ago

Health Care Roundup: Market Talk

Core & Main Announces Secondary Offering and Share Repurchase

Business Wire

6 months ago

Core & Main Announces Secondary Offering and Share Repurchase

WYNDHAM COMMENTS ON CHOICE'S SELF-SERVING DIRECTOR NOMINATIONS

PR Newswire

6 months ago

WYNDHAM COMMENTS ON CHOICE'S SELF-SERVING DIRECTOR NOMINATIONS

Alcoa Corporation (NYSE:AA) Q4 2023 Earnings Call Transcript

Insider Monkey

6 months ago

Alcoa Corporation (NYSE:AA) Q4 2023 Earnings Call Transcript

ECB Asks Banks for Details About Exposure to Spain’s Grifols

Bloomberg

6 months ago

ECB Asks Banks for Details About Exposure to Spain’s Grifols

ITT Announces New Board of Directors Appointment

Business Wire

6 months ago

ITT Announces New Board of Directors Appointment

Safety Stocks Are the Play of the Day

The Wall Street Journal

6 months ago

Safety Stocks Are the Play of the Day

Grifols Analyst Breaks Ranks With Peers After Short Seller Chaos

Bloomberg

6 months ago

Grifols Analyst Breaks Ranks With Peers After Short Seller Chaos

Should You Be Adding Encompass Health (NYSE:EHC) To Your Watchlist Today?

Simply Wall St.

6 months ago

Should You Be Adding Encompass Health (NYSE:EHC) To Your Watchlist Today?

Here's Why Grifols (GRFS) is Poised for a Turnaround After Losing -31.55% in 4 Weeks

Zacks

6 months ago

Here's Why Grifols (GRFS) is Poised for a Turnaround After Losing -31.55% in 4 Weeks

5 Top Classic Value Stocks for 2024

Zacks

6 months ago

5 Top Classic Value Stocks for 2024

Apellis Announces Preliminary Fourth Quarter and Full Year 2023 U.S. Net Product Revenues

GlobeNewswire

7 months ago

Apellis Announces Preliminary Fourth Quarter and Full Year 2023 U.S. Net Product Revenues

The Chip Wars Are Metastasizing

The Wall Street Journal

7 months ago

The Chip Wars Are Metastasizing

Here’s How Liberty Broadband Corporation (LBRDK) Faced Challenges from the Industry

Insider Monkey

8 months ago

Here’s How Liberty Broadband Corporation (LBRDK) Faced Challenges from the Industry

Share on Social Networks: